Financial News
Articles published by Pfizer Inc.
![](https://mms.businesswire.com/media/20211102005458/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
PFIZER REPORTS THIRD-QUARTER 2021 RESULTS
November 02, 2021
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20211029005549/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20211028005559/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20211026006316/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20211021005491/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20211020006069/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20211015005319/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer’s Abrocitinib Receives Positive CHMP Opinion for the Treatment of Adults with Moderate to Severe Atopic Dermatitis
October 15, 2021
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20210930005022/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Japan’s MHLW Approves Pfizer’s CIBINQO® (abrocitinib) for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
September 30, 2021
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20210929005276/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20210928005307/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20210927005588/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Starts Study of mRNA-Based Next Generation Flu Vaccine Program
September 27, 2021
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20210927005195/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Starts Global Phase 2/3 EPIC-PEP Study of Novel COVID-19 Oral Antiviral Candidate for Post-Exposure Prophylaxis in Adults
September 27, 2021
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20210923005017/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Invites Public to View and Listen to Webcast of Pfizer November 2 Conference Call with Analysts
September 23, 2021
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20210923005204/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Declares Fourth-Quarter 2021 Dividend
September 23, 2021
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20210922006046/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20210922005421/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20210920005054/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
September 20, 2021
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20210920005452/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20210917005545/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20210909005232/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20210907005040/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Invites Public to Listen to Two Webcasts of Pfizer Discussions at Upcoming Healthcare Conferences
September 07, 2021
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20210902005069/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20210830005111/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20210826005149/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Announces New Chief Business Innovation Officer
August 26, 2021
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20210826005385/en/1187634/5/190705_Biontech_Logo_RGB_Dark_Green_%28Preferred%29_0_%28002%29.jpg)
![](https://mms.businesswire.com/media/20210825005638/en/1187022/5/Biontech_Logo.jpg)
![](https://mms.businesswire.com/media/20210823005499/en/1184279/5/190705_Biontech_Logo_RGB_Dark_Green_%28Preferred%29_0_%28002%29.jpg)
![](https://mms.businesswire.com/media/20210823005192/en/1183909/5/Trillium_Logo_suggested_variation_2018_%28002%29_highres.jpg)
Pfizer to Acquire Trillium Therapeutics Inc.
August 23, 2021
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20210820005354/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20210816005723/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Prices $1.0 Billion Sustainability Bond
August 16, 2021
From Pfizer Inc.
Via Business Wire
Tickers
PFE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.